Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Jul;44(1):45–50. doi: 10.1038/bjc.1981.145

A case-control study of the possible association between oral contraceptives and malignant melanoma.

S A Adam, J K Sheaves, N H Wright, G Mosser, R W Harris, M P Vessey
PMCID: PMC2010646  PMID: 7259960

Abstract

In a case-control study, we investigated 169 women aged 15-49 years with malignant melanoma notified to the Oxford and South Western cancer registries during the years 1971-1976, together with 507 matched controls. Data about medical, reproductive, drug and smoking histories were obtained both by reviewing general practitioner (GP) records and from the women themselves by postal questionnaires. There was no significant evidence of any overall increase in the risk of melanoma in oral contraceptive (OC) users (data from GP records-ever use vs never use, relative risk (RR) 1.34, 95% confidence limits 0.92-1.96; corresponding data from postal questionnaires-RR 1.13, limits 0.73-1.75). However, although not significant, the risk estimated from data in the postal questionnaires was higher in women who had used OCs for 5 years or more (use greater than or equal to 5 years vs never use, RR 1.57, limits 0.83-3.03). Previously demonstrated risk factors for melanoma, such as fair skin, blond or red hair and Celtic origin were found to be commoner in the cases than in the controls. Data from the Oxford/Family Planning Association contraceptive study were also examined. Unexpectedly there was a strong suggestion of a negative association between OC use and melanoma risk, but the analysis was based on only 12 women with the disease.

Full text

PDF
45

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beral V., Ramcharan S., Faris R. Malignant melanoma and oral contraceptive use among women in California. Br J Cancer. 1977 Dec;36(6):804–809. doi: 10.1038/bjc.1977.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown M. M., Sharpe C. A., Macmillan D. S., McGovern V. J. Genetic predisposition to melanoma and other skin cancers in Australians. Med J Aust. 1971 Apr 17;1(16):852–853. doi: 10.5694/j.1326-5377.1971.tb87892.x. [DOI] [PubMed] [Google Scholar]
  3. Carruthers R. Chloasma and oral contraceptives. Med J Aust. 1966 Jul 2;2(1):17–20. [PubMed] [Google Scholar]
  4. Crombie I. K. Racial differences in melanoma incidence. Br J Cancer. 1979 Aug;40(2):185–193. doi: 10.1038/bjc.1979.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Elwood J. M., Lee J. A. Recent data on the epidemiology of malignant melanoma. Semin Oncol. 1975 Jun;2(2):149–154. [PubMed] [Google Scholar]
  6. Fisher R. I., Neifeld J. P., Lippman M. E. Oestrogen receptors in human malignant melanoma. Lancet. 1976 Aug 14;2(7981):337–339. doi: 10.1016/s0140-6736(76)92592-7. [DOI] [PubMed] [Google Scholar]
  7. Gellin G. A., Kopf A. W., Garfinkel L. Malignant melanoma. A controlled study of possibly associated factors. Arch Dermatol. 1969 Jan;99(1):43–48. doi: 10.1001/archderm.99.1.43. [DOI] [PubMed] [Google Scholar]
  8. Jelinek J. E. Cutaneous side effects of oral contraceptives. Arch Dermatol. 1970 Feb;101(2):181–186. [PubMed] [Google Scholar]
  9. Lee J. A. Current evidence about the causes of malignant melanoma. Prog Clin Cancer. 1975;6:151–161. [PubMed] [Google Scholar]
  10. Lee J. A., Strickland D. Malignant melanoma: social status and outdoor work. Br J Cancer. 1980 May;41(5):757–763. doi: 10.1038/bjc.1980.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Magnus K. Incidence of malignant melanoma of the skin in the five Nordic countries: significance of solar radiation. Int J Cancer. 1977 Oct 15;20(4):477–485. doi: 10.1002/ijc.2910200402. [DOI] [PubMed] [Google Scholar]
  12. Malec E., Eklund G. The changing incidence of malignant melanoma of the skin in Sweden, 1959-1968. Scand J Plast Reconstr Surg. 1978;12(1):19–27. doi: 10.3109/02844317809010476. [DOI] [PubMed] [Google Scholar]
  13. Nordlund J. J., Lerner A. B. On the causes of melanomas. Am J Pathol. 1977 Nov;89(2):443–448. [PMC free article] [PubMed] [Google Scholar]
  14. SNELL R. S., BISCHITZ P. G. The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation. J Invest Dermatol. 1960 Aug;35:73–82. doi: 10.1038/jid.1960.87. [DOI] [PubMed] [Google Scholar]
  15. Stevens R. G., Lee J. A., Moolgavkar S. H. No association between oral contraceptives and malignant melanomas. N Engl J Med. 1980 Apr 24;302(17):966–966. doi: 10.1056/NEJM198004243021713. [DOI] [PubMed] [Google Scholar]
  16. Teppo L., Pakkanen M., Hakulinsen T. Sunlight as a risk factor of malignant melanoma of the skin. Cancer. 1978 May;41(5):2018–2027. doi: 10.1002/1097-0142(197805)41:5<2018::aid-cncr2820410550>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  17. Vessey M., Doll R., Peto R., Johnson B., Wiggins P. A long-term follow-up study of women using different methods of contraception--an interim report. J Biosoc Sci. 1976 Oct;8(4):373–427. doi: 10.1017/s0021932000010890. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES